|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02327 MEILLEUREHEALTH
Nominal 
0.255 0.000 (0.000%) | 2024/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Turnover | 30,033 | -59.869% | 129,304 | 119,894 | 253,031 | 265,135 |
| Cost of Sales | (14,640) | -61.361% | (51,214) | (53,133) | (152,102) | (153,884) |
| Gross Profit | 15,393 | -58.340% | 78,090 | 66,761 | 100,929 | 111,251 |
| 2024/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | (20,429) | -- | 20,086 | 13,581 | 15,190 | (16,869) | |
| Change in FV & Impairment on Others | -- | -- | (3,962) | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | 3,900 | 9,435 | 14,844 | 45,785 | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (1,720) | -37.996% | (4,353) | (14,774) | (11,068) | (4,201) | |
| Profit / (Loss) before Taxation | 8,025 | -62.050% | 52,983 | 25,385 | 85,704 | 103,587 | |
| Taxation | 205 | -- | (14,493) | (7,605) | (25,248) | (18,521) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 235 | -45.093% | 2,340 | 42 | (133) | (1,627) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 8,465 | -53.387% | 40,830 | 17,822 | 60,323 | 83,439 | |
| 2024/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Net Finance Costs / (Income) | (2,785) | -31.505% | (7,416) | (15,460) | (4,064) | 5,445 |
| Depreciation & Amortisation | -- | -- | 2,639 | 3,852 | 3,576 | 7,909 |
| Directors' Emoluments | -- | -- | 1,693 | 2,614 | 3,938 | 4,566 |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | 0.210 | -52.273% | 1.000 | 0.430 | 1.420 | 1.950 |
| DPS (cts) | 0.000 | -- | 0.400 | 1.600 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | 40.000% | 372.093% | -- | -- |
| Cash flow per share ($) | -- | -- | (0.033) | 0.011 | (0.020) | 0.017 |
| NBV per share ($) | 0.298 | -- | 0.306 | 0.323 | 0.339 | 0.328 |
| Remarks: | Real time quote last updated: 15/11/2024 10:06 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD 8,465,000 |
| %Change | -53.387% |
| EPS / (LPS) | HKD 0.002 |
| NBV Per Share ($) | HKD 0.298 |